Most peptides discussed as research compounds are synthetic analogues of nuclear-encoded proteins. MOTS-c is not. It is encoded within mitochondrial DNA, and that single fact is what makes it scientifically distinctive.
What MOTS-c is
MOTS-c stands for mitochondrial open reading frame of the twelve S ribosomal RNA type-c. It is a sixteen-residue peptide encoded by a short open reading frame inside the mitochondrial 12S rRNA gene.
Mitochondria carry their own small circular genome, a remnant of their bacterial ancestry, and it was long assumed to encode only a handful of respiratory chain components and the RNAs needed to translate them. The discovery that it also encodes regulatory peptides changed that picture.
Retrograde signalling
Communication between nucleus and mitochondria was historically understood as largely one-directional: the nucleus encodes most mitochondrial proteins and directs their import. Signalling in the other direction, from mitochondria back to the nucleus, is termed retrograde signalling.
MOTS-c is a concrete molecular example. Kim and colleagues demonstrated in Cell Metabolism that under metabolic stress the peptide translocates to the nucleus and regulates nuclear gene expression.[2] A mitochondrially encoded peptide entering the nucleus to alter transcription is a clean demonstration of the mitochondrion acting as a signalling organelle rather than solely a power plant.
What the published research examines
The founding study
Lee and colleagues introduced MOTS-c in Cell Metabolism in 2015, reporting effects on metabolic homeostasis in mouse models.[1] The mechanistic account centred on the folate cycle and downstream AMPK activation, AMPK being the principal cellular energy sensor. That paper remains the reference point for the field.
Subsequent work
Research since has extended across several areas. A 2019 study in the International Journal of Molecular Sciences examined adipose thermogenic activation and cold adaptation. Mohtashami and colleagues reviewed the ageing literature in the same journal.[4] Zheng and colleagues surveyed the field in Frontiers in Endocrinology.[3]
The breadth here is a double-edged observation. A peptide acting on a central energy-sensing pathway would be expected to show effects across many systems, but breadth of reported effect also makes specific mechanistic attribution harder.
Handling and stability
MOTS-c is supplied as a lyophilised solid, stored at −20°C and protected from light and moisture. Reconstitution follows standard practice: sterile solvent down the vial wall, gentle swirling, no vortexing.
At sixteen residues MOTS-c sits in the size range where aggregation in solution is a practical concern, particularly at higher concentrations or after freeze-thaw cycling. Visual inspection of reconstituted material before use, and single-use aliquots, both reduce a common source of between-run variability.
What the literature does not establish
MOTS-c research is young by the standards of the field, with the founding paper published in 2015. The literature is correspondingly thinner and less replicated than for longer-studied compounds.
Most work is in rodent models and cell culture. The relationship between circulating MOTS-c concentrations and the concentrations applied in experimental systems is not well characterised, and mitochondrial DNA haplogroup variation between individuals and strains adds a source of variability that is rarely controlled for. Treat strong claims about this peptide with proportionate caution.
References
- Lee C. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015. PMID 25738459
- Kim KH. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metabolism. 2018. PMID 29983246
- Zheng Y. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Frontiers in Endocrinology. 2023. PMID 36761202
- Mohtashami Z. MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases. International Journal of Molecular Sciences. 2022. PMID 36233287
Research use only
MOTS-c is supplied by MMpeptides strictly for laboratory and in vitro research. It is not approved for human or veterinary use, is not a cosmetic or medicinal product, and nothing in this article should be read as describing use in people. Third-party studies are cited for scientific context only. Researchers are responsible for observing all applicable regulations in their jurisdiction.